Sight Sciences 

$9.32
5
-$0.25-2.61%Friday 19:59
+$0.00+0%Friday 20:04After hours

Statistics

Day High
9.34
Day Low
9.28
52W High
9.71
52W Low
3.38
Volume
19,322
Avg. Volume
-
Mkt Cap
513.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 4Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.28
-0.22
-0.15
-0.08
Expected EPS
-0.123254
Actual EPS
N/A

Financials

-49.67%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
77.36MRevenue
-38.43MNet Income

Analyst Ratings

$9.33Average Price Target
The highest estimate is ⁦14.00⁩.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SGHT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap10.21B
Align Technology provides medical devices for dental procedures, competing in the broader medical device market similar to Sight Sciences' focus on ophthalmic and optometric devices.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson offers a wide range of medical devices, including those for eye health, directly competing with Sight Sciences' products in the ophthalmology sector.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie, through its acquisition of Allergan, competes in the eye care market, particularly in treatments for conditions like dry eye, which could overlap with Sight Sciences' patient demographic.
Novartis
NVS
Mkt Cap268B
Novartis provides advanced eye care products through its Alcon division, making it a direct competitor in the ophthalmology and optometry markets.
Cooper Companies
COO
Mkt Cap10.82B
The Cooper Companies specialize in contact lens and medical devices for eye care, positioning them as competitors in the vision health market alongside Sight Sciences.
Bausch Health Companies
BHC
Mkt Cap2.17B
Bausch Health Companies, through its eye health division, offers products that compete in the same space as Sight Sciences, particularly in surgical and pharmaceutical eye care.
Staar Surgical
STAA
Mkt Cap1.13B
STAAR Surgical specializes in implantable lenses and other products for the eye, competing with Sight Sciences in the area of surgical interventions for vision correction.
Integra Lifesciences
IART
Mkt Cap986.16M
Integra LifeSciences manufactures medical devices, including those for eye surgery, competing with Sight Sciences in the broader market for surgical medical devices.
Penumbra
PEN
Mkt Cap12.51B
Penumbra, Inc. offers innovative medical devices across various fields, including a potential overlap in the eye care sector, positioning it as a competitor in the medical device market.

About

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Show More
CEO
Paul Badawi
Employees
186
Country
United States
ISIN
US82657M1053

Listings

0 Comments

Share your thoughts

FAQs

What is Sight Sciences stock price today?▼
The current price of SGHT is $9.32 USD — it has decreased by -2.61% in the past 24 hours. Watch Sight Sciences stock price performance more closely on the chart.
What is Sight Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sight Sciences stocks are traded under the ticker SGHT.
Is Sight Sciences stock price growing?▼
SGHT stock has risen by +3.33% compared to the previous week, the month change is a +9.26% rise, over the last year Sight Sciences has showed a +84.19% increase.
What is Sight Sciences market cap?▼
Today Sight Sciences has the market capitalization of 513.42M
When is the next Sight Sciences earnings date?▼
Sight Sciences is going to release the next earnings report on November 4, 2026.
What were Sight Sciences earnings last quarter?▼
SGHT earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.17 USD resulting in a +51.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sight Sciences revenue for the last year?▼
Sight Sciences revenue for the last year amounts to 77.36M USD.
What is Sight Sciences net income for the last year?▼
SGHT net income for the last year is -38.43M USD.
How many employees does Sight Sciences have?▼
As of November 2, 2026, the company has 186 employees.
In which sector is Sight Sciences located?▼
Sight Sciences operates in the Health & Wellness sector.
When did Sight Sciences complete a stock split?▼
Sight Sciences has not had any recent stock splits.
Where is Sight Sciences headquartered?▼
Sight Sciences is headquartered in MENLO PARK, United States.